Neovascular age-related macular degeneration: opportunities for development of first-in-class biopharmaceuticals.
about
Neovascular age-related macular degeneration: opportunities for development of first-in-class biopharmaceuticals.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Neovascular age-related macula ...... t-in-class biopharmaceuticals.
@en
Neovascular age-related macula ...... t-in-class biopharmaceuticals.
@nl
type
label
Neovascular age-related macula ...... t-in-class biopharmaceuticals.
@en
Neovascular age-related macula ...... t-in-class biopharmaceuticals.
@nl
prefLabel
Neovascular age-related macula ...... t-in-class biopharmaceuticals.
@en
Neovascular age-related macula ...... t-in-class biopharmaceuticals.
@nl
P2093
P2860
P1433
P1476
Neovascular age-related macula ...... t-in-class biopharmaceuticals.
@en
P2093
Gert Storm
Raymond M Schiffelers
Tjitske K van der Vaart
P2860
P304
P356
10.2165/11589330-000000000-00000
P577
2011-06-01T00:00:00Z